191 Documents disponibles chez cet éditeur
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverte[...]
Being young in Europe today' presents some of Eurostat's most interesting data on children and young people in the European Union. It gives an insight into the past, current and future situation of our youngest fellow citizens, ranging from atte[...]
This publication answers some of the more frequently asked questions raised in discussions about cannabis legislation. While the primary focus is on the use of cannabis for recreational purposes, relevant legislation for other uses, including me[...]
At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the[...]
OEDT = EMCDDA ; L. LANIEL ; M. GANDILHON ; J. E. ADES ; A. CUNNINGHAM ; N. SINGLETON ; R. SEDEFOV ; P. GRIFFITHS | 2018
RapportCaptagon is reported to be a commonly used stimulant in the Middle East. In addition, some recent media reports have linked this drug to perpetrators of terrorist acts in Europe or terrorist groups based in areas of conflict in the Middle East. [...]![Carfentanil. Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_80450.webp?v=1776271750)
This publication presents the data and findings of the risk assessment on methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2[...]
The purpose of this paper is to give meaning and insight into some of the key drug and alcohol issues that affect children from the perspectives of the children themselves. It is not to estimate the relative magnitude of a specific drug or alcoh[...]
Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]
Community coalitions are a strategy to coordinate activities and resources to prevent adolescent substance use and delinquent behaviour. They can help mobilise communities in prevention and health promotion initiatives. The Communities That Car[...]
OEDT = EMCDDA ; M. TORRENS ; J. I. MESTRE-PINTO ; A. DOMINGO-SALVANY ; L. MONTANARI ; J. VICENTE | 2015
RapportThis publication looks at the co-occurrence of drug use problems and mental health disorders, taking in the theoretical background of psychiatric comorbidity, the tools for clinical diagnosis and the prevalence and clinical relevance of the prob[...]
This publication presents the data and findings of the risk assessment on 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017.[...]![Cyclopropylfentanyl. Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_80916.webp?v=1776258574)
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018.[...]
This paper presents the EMCDDA's current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction - building on the work completed in this area and expanding to reflect the academic research underpinning this [...]
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | 2019
RapportENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]
OEDT = EMCDDA ; H. SCHULZE, Coordonnateur ; M. SCHUMACHER ; R. URMEEW ; K. AUERBACH ; J. ALVAREZ ; I. M. BERNHOFT ; H. DE GIER ; M. HAGENZIEKER ; S. HOUWING ; A. KNOCHE ; B. PILGERSTORFER ; B. ZLENDER ; B. HUGHES ; L. VANDAM | 2012
RapportThis Thematic paper presents the key findings of the European Union’s research project on Driving Under the Influence of Drugs, Alcohol and Medicines, known as the DRUID project. The project looked at experimental studies, epidemiological studie[...]
Historique
